(HOVON) (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group of European Organisation for the Research and Treatment of Cancer AML-11, a Phase III Randomized Study of the Leukemia Cooperative Group 61 Years and Older With Acute Myeloid Leukemia (AML): Final Report of During and After Remission Induction Chemotherapy in Patients Aged Use of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor